MOLECULAR TEMPLATES ($MTEM) is expected to release its quarterly earnings data on Thursday, March 27th after market close, per Finnhub. Analysts are expecting revenue of $351,900 and earnings of -$0.89 per share.
You can see Quiver Quantitative's $MTEM stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MOLECULAR TEMPLATES Insider Trading Activity
MOLECULAR TEMPLATES insiders have traded $MTEM stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MTEM stock by insiders over the last 6 months:
- TARGET N V BIOTECH sold 1,279,820 shares for an estimated $845,833
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MOLECULAR TEMPLATES Hedge Fund Activity
We have seen 1 institutional investors add shares of MOLECULAR TEMPLATES stock to their portfolio, and 28 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BELLEVUE GROUP AG removed 1,279,820 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $51,192
- SILVERARC CAPITAL MANAGEMENT, LLC removed 623,838 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $24,953
- BVF INC/IL removed 522,238 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $20,889
- CAXTON CORP removed 136,866 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $192,296
- BANK OF MONTREAL /CAN/ removed 73,125 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $2,925
- VANGUARD GROUP INC removed 50,899 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $2,035
- GEODE CAPITAL MANAGEMENT, LLC removed 47,231 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $1,889
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
